BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13379520)

  • 41. Antibiotic combinations and resistance to antibiotics: penicillin with other antibiotics against penicillin-resistant staphylococci.
    FINLAND M; WILCOX C
    Proc Soc Exp Biol Med; 1953 Jul; 83(3):605-8. PubMed ID: 13088924
    [No Abstract]   [Full Text] [Related]  

  • 42. [Sensitivity of Staphylococcus aureus in vitro to erythromycin, oleandomycin triacetate and novobiocin in suppurative surgical diseases].
    DOLEZALOWA M; ZASOWSKI A
    Pol Przegl Chir; 1962 Feb; 34():131-6. PubMed ID: 13887010
    [No Abstract]   [Full Text] [Related]  

  • 43. Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds.
    Knothe H
    Infection; 1977; 5(3):137-9. PubMed ID: 914361
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Development and modifications of the resistance of pathogenic staphylococci to six common antibiotics from 1950 to 1956; comparative action in vitro of erythromycin, magnamycin, spiramycin, novobiocin (albamycin) and oleandomycin].
    LUTZ A; GROOTTEN O; HOFFERER MJ
    Ann Inst Pasteur (Paris); 1957 Jun; 92(6):778-89. PubMed ID: 13444794
    [No Abstract]   [Full Text] [Related]  

  • 45. Mechanism of action of spiramycin and other macrolides.
    Brisson-Noël A; Trieu-Cuot P; Courvalin P
    J Antimicrob Chemother; 1988 Jul; 22 Suppl B():13-23. PubMed ID: 3053566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. REPORT OF THE USE OF DRUG SENSITIVITY TESTS IN GENERAL PRACTICE.
    HUGHES JB; BRAILEY HM; EDGAR ML
    Med J Aust; 1964 Jan; 1():72-4. PubMed ID: 14118193
    [No Abstract]   [Full Text] [Related]  

  • 47. Participation of erythromycin and carbomycin in combined antibiotic action in vitro.
    COLEMAN VR; GUNNISON JB; JAWETZ E
    Proc Soc Exp Biol Med; 1953; 83(4):668-70. PubMed ID: 13120847
    [No Abstract]   [Full Text] [Related]  

  • 48. In vitro sensitivity of 300 strains of Micrococcus pyogenes isolated from carriers to seven antibiotics; the problem of the resistant Staphylococci in Chile.
    PAREDES L; VACCARO H; VALENZUELA E
    Antibiot Annu; 1955-1956; 3():623-33. PubMed ID: 13355339
    [No Abstract]   [Full Text] [Related]  

  • 49. DRUG RESISTANCE OF STAPHYLOCOCCI. II. JOINT ELIMINATION AND JOINT TRANSDUCTION OF THE DETERMINANTS OF PENICILLINASE PRODUCTION AND RESISTANCE TO MACROLIDE ANTIBIOTICS.
    MITSUHASHI S; HASHIMOTO H; KONO M; MORIMURA M
    J Bacteriol; 1965 Apr; 89(4):988-92. PubMed ID: 14276126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [DISTRIBUTION OF "STAPHYLOCOCCUS AUREUS" IN THE HOSPITALS OF SAINT-ETIENNE].
    COURTIEU AL; CELLIERE M
    J Med Lyon; 1963 Apr; 44():743-55. PubMed ID: 14076449
    [No Abstract]   [Full Text] [Related]  

  • 51. In vivo induction of resistance to macrolide antibiotics in staphylococci with erythromycin.
    Kurashige S; Inoue M; Yamaguchi N; Mitsuhashi S
    Jpn J Microbiol; 1972 Jan; 16(1):21-5. PubMed ID: 4537712
    [No Abstract]   [Full Text] [Related]  

  • 52. In vitro activity against Micrococcus pyogenes of various combinations of antimicrobial agents.
    WAISBREN BA
    J Lab Clin Med; 1955 Oct; 46(4):583-91. PubMed ID: 13263739
    [No Abstract]   [Full Text] [Related]  

  • 53. Comparative efficacy of clindamycin, erythromycin and spiramycin against Staphylococcus aureus in the rat croton oil pouch model.
    Davey PG; Jacobus NV; Tally FP
    J Antimicrob Chemother; 1987 Nov; 20(5):705-12. PubMed ID: 3429372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spiramycin; clinical and laboratory studies.
    HUDSON DG; YOSHIHARA GM; KIRBY WM
    AMA Arch Intern Med; 1956 Jan; 97(1):57-61. PubMed ID: 13275148
    [No Abstract]   [Full Text] [Related]  

  • 55. Structure-activity relation among macrolide antibiotics in initiation of interdigestive migrating contractions in the canine gastrointestinal tract.
    Itoh Z; Suzuki T; Nakaya M; Inoue M; Arai H; Wakabayashi K
    Am J Physiol; 1985 Mar; 248(3 Pt 1):G320-5. PubMed ID: 3976891
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [STUDY ON THE COMBINED EFFECT OF MIXTURES OF TETRACYCLINE AND PREPARATIONS FROM THE MACROLID GROUP ON STAPHYLOCOCCI RESISTANT TO VARIOUS ANTIBIOTICS].
    MOROZ AF
    Antibiotiki; 1963 Sep; 8():807-11. PubMed ID: 14130402
    [No Abstract]   [Full Text] [Related]  

  • 57. Antibiotic combinations and resistance to antibiotics; penicillin-erythromycin and streptomycin-erythromycin combinations in vitro.
    PURCELL EM; WRIGHT SS; FINLAND M
    Proc Soc Exp Biol Med; 1953 Jan; 82(1):124-31. PubMed ID: 13037821
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of fixed combinations of antibiotics on Staphylococci in vitro.
    FURESZ S; ZANGAGLIA O; SCOTTI R
    Antibiot Chemother (Northfield); 1958 Nov; 8(11):571-5. PubMed ID: 24544980
    [No Abstract]   [Full Text] [Related]  

  • 59. Inducible resistance to a 16-membered macrolide, mycinamicin, in Staphylococcus aureus resistant to 14-membered macrolides and streptogramin B antibiotics.
    Nakajima Y; Jánosi L; Endou K; Matsuoka M; Hashimoto H
    J Pharmacobiodyn; 1992 Jun; 15(6):319-24. PubMed ID: 1432570
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Novobiocin and PA 105: in vitro and in vivo studies on effectiveness against Micrococcus pyogenes.
    NOYES HE; NAGLE SC; SANFORD JP; ROBBINS ML
    Antibiot Chemother (Northfield); 1956 Jul; 6(7):450-5. PubMed ID: 24544026
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.